A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Clinical trial NCT02713256 · COMPLETED
Trial details
- NCT number
- NCT02713256
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-19
- Primary completion
- 2017-04-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.